Abstract
We conducted surveillance of respiratory syncytial virus (RSV) genomic sequences for 100 RSV-A and 27 RSV-B specimens collected during November 2022–April 2023 in Arizona, USA. We identified mutations within prefusion F-protein antigenic sites in both subtypes. Continued genomic surveillance will be critical to ensure RSV vaccine effectiveness.
Original language | English (US) |
---|---|
Pages (from-to) | 2380-2382 |
Number of pages | 3 |
Journal | Emerging Infectious Diseases |
Volume | 29 |
Issue number | 11 |
DOIs | |
State | Published - Nov 2023 |
ASJC Scopus subject areas
- Epidemiology
- Microbiology (medical)
- Infectious Diseases